Well 2023 was deflating, and it is all now out in the open.
Yes the SP has sunk to an all time low, and we hope our BoDs have learnt not to challenge, but obey.
Stem Cell therapy is booming in the USA beyond what the FDA has control of. They are doing their best to catch up but obviously need the first company to prove its worth and consistency.
I repeat, the FDA will not stop stem cell treatments, as it is already expanding at a greater rate than cosmetic surgery ever did.
They will need to approve it for a standard therapy, or look like fools.
Ann: Update on Institutional Placement and Entitlement Offer, page-370
-
- There are more pages in this discussion • 143 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.025(2.17%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.16 | $1.11 | $7.363M | 6.488M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 94863 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 5000 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |